Swiss reimbursement system for medical devices and IVD tests
This online on-demand seminar gives a comprehensive understanding of the hospital reimbursement landscape for medical devices in Switzerland. Additional modules cover reimbursement of IVD tests, screening methods, and out-patient reimbursement system
Available as a pre-recorded webinar or full presentation in Acrobat PDF
Switzerland is a very attractive market for innovative medical device companies.
Easiness of creation of procedure code at the hospital level (CHOP code), high tariffs for hospital care and lack of mandatory evidence review for novel procedures make Switzerland a very interesting market for medical device companies with hospital products.
The key challenges in the market are the development of procedure code and adjustment of the DRG system (including the creation of add-on reimbursement). Also, new methods can be questioned by insurance companies and routed for national health technology assessment by the Federal Office of Public Health. In such cases, based on the manufacturer’s submission, the Office decides about coverage of the procedure in the statutory health insurance.
We offer a seminar on critical elements of the hospital reimbursement system for medical devices in Switzerland that can guide your decision-making about the introduction of novel technologies into this market.
What topics are reviewed?
Key stakeholders and their role in reimbursement processes
Key stakeholders are reviewed, including payers, policy-makers, advising organizations (including partners of SwissDRG) and support bodies (developer of procedural classification/DRG system)
Money flow and hospital payment system
Money flow and distribution of funds, an overview of the hospital payment system (DRG system), the process of development of the DRG system
Funding and health technology assessment landscape
Funding framework, including coverage of services within statutory health insurance (KLV List). HTA landscape and role of HTA in market access
Additional modules
Reimbursement system for in-vitro diagnostic tests
A separate comprehensive overview of the reimbursement system for IVD tests in Switzerland
Organization and financing of screening methods
A separate comprehensive overview of the organizational and financing framework of screening methods (e.g. breast and cervical cancer screening) in Switzerland
Out-patient reimbursement system
A separate comprehensive overview of the out-patient reimbursement system in Switzerland
What topics are not covered?
Some topics are not specifically covered in this seminar: reimbursement for medical aids (devices for home use), funding of capital equipment
The introductory presentation also does not include details of reimbursement application processes (for example, application form, requirements, details of the process for the creation of procedure code or DRG change)
Topics that are not covered in this seminar will be included in future courses. You can subscribe to our newsletter and inform us about your particular interests at the main page of the Market Access Academy
How is the seminar delivered?
Option #1: Pre-recorded webinar
One option is to watch the seminar, which is provided as a pre-recorded webinar. The duration of the webinar is 23 minutes. Webinar is available for 6 months
Option #2: Presentation in Acrobat PDF
You can also access just the educational material - the full presentation of the seminar in Acrobat PDF
View extract from the seminar
This 1-minute extract presents the overview of integration of novel procedure into DRG system
Updates of the seminar
July 2020: Update of the overview of the Swiss reimbursement system (Substantial update of the section about the role of HTA in market access for medical technologies)
Request a quote
Click the button below to request a quote for the seminar
